These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 367896)

  • 61. Adjuvant immunotherapy of malignant melanoma.
    Aranha GV; McKhann CF; Grage TB; Gunnarsson A; Simmons RL
    Cancer; 1979 Apr; 43(4):1297-303. PubMed ID: 445331
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemotherapy of metastatic malignant melanoma. Experience with 73 patients.
    Johnson FD; Jacobs EM
    Cancer; 1971 Jun; 27(6):1306-12. PubMed ID: 4253429
    [No Abstract]   [Full Text] [Related]  

  • 63. Adjuvant chemoimmunotherapy stage I/II malignant melanoma.
    Knost JA; Reynolds V; Greco FA; Oldham RK
    J Surg Oncol; 1982 Mar; 19(3):165-70. PubMed ID: 7040820
    [No Abstract]   [Full Text] [Related]  

  • 64. Some drugs for treating neoplasms.
    Healy JB
    Ir Med J; 1978 May; 71(8):264-7. PubMed ID: 77265
    [No Abstract]   [Full Text] [Related]  

  • 65. Immunotherapy and chemotherapy in children with neuroblastoma.
    Nesbit ME; Kersey J; Finklestein J; Weiner J; Simmons R
    J Natl Cancer Inst; 1976 Sep; 57(3):717-20. PubMed ID: 978774
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.
    Hedley DW; McElwain TJ; Currie GA
    Br J Cancer; 1978 Apr; 37(4):491-6. PubMed ID: 646922
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Therapy of malignant melanoma].
    Balch CM
    Dtsch Med Wochenschr; 1985 Nov; 110(46):1786-91. PubMed ID: 4054006
    [No Abstract]   [Full Text] [Related]  

  • 68. Improved systemic chemotherapy for malignant melanoma.
    Larsen RR; Hill GJ
    Am J Surg; 1971 Jul; 122(1):36-41. PubMed ID: 5091852
    [No Abstract]   [Full Text] [Related]  

  • 69. Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.
    Newlands ES; Oon CJ; Roberts JT; Elliott P; Mould RF; Topham C; Madden FJ; Newton KA; Westbury G
    Br J Cancer; 1976 Aug; 34(2):174-9. PubMed ID: 962994
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunochemotherapy of human cancer.
    Gutterman JU; Mavligit GM; Reed RC; Hersh EM
    Semin Oncol; 1974 Dec; 1(4):409-23. PubMed ID: 4620443
    [No Abstract]   [Full Text] [Related]  

  • 71. Adjuvant therapy in malignant melanoma: a trial of immunotherapy. chemotherapy, and combined treatment.
    Kaufman SD; Cosimi AB; Wood WC; Carey RW
    Recent Results Cancer Res; 1978; 68():380-6. PubMed ID: 752874
    [No Abstract]   [Full Text] [Related]  

  • 72. Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report.
    Veronesi U; Beretta G
    Recent Results Cancer Res; 1978; 68():375-9. PubMed ID: 752873
    [No Abstract]   [Full Text] [Related]  

  • 73. Adjuvant chemotherapy or chemoimmunotherapy in the management of primary malignant melanoma of level III, IV, or V.
    Jacquillat C; Banzet P; Civatte J; Puissant A; Cottenot F; Israel L; Belaich S; Chastang C; Maral J
    Recent Results Cancer Res; 1978; 68():346-58. PubMed ID: 111323
    [No Abstract]   [Full Text] [Related]  

  • 74. Active immunotherapy with B.C.G. for recurrent malignant melanoma.
    Gutterman JU; Mavligit G; McBride C; Frei E; Freireich EJ; Hersh EM
    Lancet; 1973 Jun; 1(7814):1208-12. PubMed ID: 4122562
    [No Abstract]   [Full Text] [Related]  

  • 75. Regression of intradermal malignant melanoma after intralesional injection of Mycobacterium bovis strain BCG.
    Nathanson L
    Cancer Chemother Rep; 1972 Oct; 56(5):659-65. PubMed ID: 4569059
    [No Abstract]   [Full Text] [Related]  

  • 76. An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs.
    Fodstad O; Aass N; Pihl A
    Br J Cancer; 1980 May; 41(5):829-31. PubMed ID: 7426308
    [No Abstract]   [Full Text] [Related]  

  • 77. Management of malignant melanoma.
    McBride CM
    Adv Surg; 1974; 8():129-150. PubMed ID: 4460688
    [No Abstract]   [Full Text] [Related]  

  • 78. Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice.
    Bistoni F; Marconi P; Pitzurra M; Frati L; Spreafico F; Goldin A; Bonmassar E
    Eur J Cancer (1965); 1979 Nov; 15(11):1305-14. PubMed ID: 393515
    [No Abstract]   [Full Text] [Related]  

  • 79. [Melanoma: a new interferon is coming ... handle with care!].
    Négrier S
    Bull Cancer; 1997 Apr; 84(4):435-7. PubMed ID: 9238171
    [No Abstract]   [Full Text] [Related]  

  • 80. [Influence and importance of dacarbazine and BCG in sonography of the liver (author's transl)].
    Crone-Münzebrock W; Denkhaus H; Voigt H
    Rontgenblatter; 1981 Aug; 34(8):317-20. PubMed ID: 7280510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.